A Randomized Phase II Study of Bevacizumab in Combination With Docetaxel in Locally Advanced Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2013
At a glance
- Drugs Bevacizumab (Primary) ; Docetaxel
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 14 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jun 2011 Planned End Date changed from 1 Sep 2012 to 1 Apr 2015 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History